Article
Amgen to buy ChemoCentryx for $3.7 billion
Rating:
0.0
Views:
51
Likes:
1
Library:
1
Amgen Inc said on Thursday it would buy ChemoCentryx Inc for $3.7 billion to gain access to the company's anti-inflammation drug.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value